What Trump’s win means for biotech and pharma
With Donald Trump now poised to become U.S. president for the second time in January, biotech and pharmaceutical leaders are ...
With Donald Trump now poised to become U.S. president for the second time in January, biotech and pharmaceutical leaders are ...
This is Part 5 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug ...
An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare ...
Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company ...
An experimental GLP-1 obesity drug from Terns Pharmaceuticals led to a 5.5% reduction in body weight in a small study, ...
Former President Donald Trump and Vice President Kamala Harris have a rare point of agreement in their otherwise bitter and ...
The millions of people who regularly suffer from heartburn now have a new FDA-approved treatment option, a Phathom Pharmaceuticals drug ...
Insilico Medication("Insilico"), a clinical-stage generative synthetic intelligence (AI)-driven drug discovery firm, has efficiently delivered the second preclinical candidate compound (PCC) ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.